Search Results

There are 8541 results for: content related to: Lack of Effect of Testosterone and Dihydrotestosterone Compared to 17β-Oestradiol in 1-Methyl-4-Phenyl-1,2,3,6, Tetrahydropyridine-Mice

  1. Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice

    Journal of Neuroendocrinology

    Volume 17, Issue 8, August 2005, Pages: 509–517, S. Jourdain, M. Morissette, N. Morin and T. Di Paolo

    Version of Record online : 1 JUL 2005, DOI: 10.1111/j.1365-2826.2005.01337.x

  2. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury

    Journal of Neuroscience Research

    Volume 88, Issue 3, 15 February 2010, Pages: 650–668, Jon-Eric VanLeeuwen, Giselle M. Petzinger, John P. Walsh, Garnik K. Akopian, Marta Vuckovic and Michael W. Jakowec

    Version of Record online : 10 SEP 2009, DOI: 10.1002/jnr.22216

  3. Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse

    Journal of Neuroscience Research

    Volume 91, Issue 11, November 2013, Pages: 1492–1507, N. Kintz, G.M. Petzinger, G. Akopian, S. Ptasnik, C. Williams, M.W. Jakowec and J.P. Walsh

    Version of Record online : 6 AUG 2013, DOI: 10.1002/jnr.23260

  4. Effect of Oestrogen Receptors on Brain NMDA Receptors of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice

    Journal of Neuroendocrinology

    Volume 24, Issue 11, November 2012, Pages: 1375–1385, S. Al-Sweidi, M. Morissette and T. Di Paolo

    Version of Record online : 16 OCT 2012, DOI: 10.1111/j.1365-2826.2012.02349.x

  5. Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

    Journal of Comparative Neurology

    Volume 504, Issue 6, 20 October 2007, Pages: 690–701, Gilmor I. Keshet, Ravi J. Tolwani, Angelica Trejo, Peggy Kraft, Regis Doyonnas, Carol Clayberger, James M. Weimann and Helen M. Blau

    Version of Record online : 22 AUG 2007, DOI: 10.1002/cne.21483

  6. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

    Journal of Neurochemistry

    Volume 136, Issue 2, January 2016, Pages: 373–387, Ana B. Muñoz-Manchado, Javier Villadiego, Sonia Romo-Madero, Nela Suárez-Luna, Alfonso Bermejo-Navas, José A. Rodríguez-Gómez, Pablo Garrido-Gil, José L. Labandeira-García, Miriam Echevarría, José López-Barneo and Juan J. Toledo-Aral

    Version of Record online : 24 NOV 2015, DOI: 10.1111/jnc.13409

  7. You have free access to this content
    Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

    Journal of Neuroendocrinology

    Volume 24, Issue 1, January 2012, Pages: 48–61, S. Al Sweidi, M. G. Sánchez, M. Bourque, M. Morissette, D. Dluzen and T. Di Paolo

    Version of Record online : 20 DEC 2011, DOI: 10.1111/j.1365-2826.2011.02193.x

  8. You have full text access to this OnlineOpen article
    Near-infrared light is neuroprotective in a monkey model of Parkinson disease

    Annals of Neurology

    Volume 79, Issue 1, January 2016, Pages: 59–75, Fannie Darlot, Cécile Moro, Nabil El Massri, Claude Chabrol, Daniel M. Johnstone, Florian Reinhart, Diane Agay, Napoleon Torres, Dhaïf Bekha, Vincent Auboiroux, Thomas Costecalde, Cassandra L. Peoples, Helena D. T. Anastascio, Victoria E. Shaw, Jonathan Stone, John Mitrofanis and Alim-Louis Benabid

    Version of Record online : 12 DEC 2015, DOI: 10.1002/ana.24542

  9. You have free access to this content
    Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Journal of Neurochemistry

    Volume 122, Issue 5, September 2012, Pages: 1032–1046, Sophie Schumm, Claude Sebban, Charles Cohen-Salmon, Jacques Callebert, Jean-Marie Launay, Jean-Louis Golmard, Lydie Boussicault, Isabelle Petropoulos, Audrey Hild, Estelle Rousselet, Annick Prigent, Bertrand Friguet, Jean Mariani and Etienne C. Hirsch

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1471-4159.2012.07837.x

  10. You have free access to this content
    Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions

    Journal of Neurochemistry

    Volume 109, Issue 5, June 2009, Pages: 1469–1482, Claire Gibrat, Martine Saint-Pierre, Mélanie Bousquet, Daniel Lévesque, Claude Rouillard and Francesca Cicchetti

    Version of Record online : 28 MAR 2009, DOI: 10.1111/j.1471-4159.2009.06072.x

  11. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

    Journal of Neuroscience Research

    Volume 88, Issue 7, 15 May 2010, Pages: 1522–1536, Hironori Yokoyama, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato and Tsutomu Araki

    Version of Record online : 8 DEC 2009, DOI: 10.1002/jnr.22310

  12. You have free access to this content
    MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2354–2368, Guoqi Zhu, Junyao Li, Ling He, Xuncui Wang and Xiaoqi Hong

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13061

  13. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys

    Journal of Neuroscience Research

    Volume 87, Issue 2, 1 February 2009, Pages: 586–597, Pablo Garrido-Gil, Silvia Belzunegui, Waldy San Sebastián, Amaya Izal-Azcárate, Berta López, Irene Marcilla and Maria Rosario Luquin

    Version of Record online : 16 SEP 2008, DOI: 10.1002/jnr.21845

  14. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  15. You have free access to this content
    The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

    Journal of Neurochemistry

    Volume 76, Issue 5, March 2001, Pages: 1265–1274, Serge Przedborski, Vernice Jackson-Lewis, Ali B. Naini, Michael Jakowec, Giselle Petzinger, Reginald Miller and Muhammad Akram

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00183.x

  16. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 12, December 2015, Pages: 1849–1864, Lacey Pflibsen, Katherine A. Stang, Michelle D. Sconce, Vanessa B. Wilson, Rebecca L. Hood, Charles K. Meshul and Suzanne H. Mitchell

    Version of Record online : 31 AUG 2015, DOI: 10.1002/jnr.23638

  17. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

    Journal of Pineal Research

    Volume 58, Issue 3, April 2015, Pages: 262–274, Amit Naskar, Visakh Prabhakar, Raghavendra Singh, Debashis Dutta and Kochupurackal P. Mohanakumar

    Version of Record online : 23 FEB 2015, DOI: 10.1111/jpi.12212

  18. You have free access to this content
    MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 582–593, GuoQi Zhu, YuYing Huang, Ying Chen, YingHan Zhuang and Thomas Behnisch

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07815.x

  19. You have free access to this content
    Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid

    Journal of Neurochemistry

    Volume 107, Issue 3, November 2008, Pages: 701–711, Daniel Alvarez-Fischer, Serge Guerreiro, Stéphane Hunot, Françoise Saurini, Marc Marien, Pierre Sokoloff, Etienne C. Hirsch, Andreas Hartmann and Patrick P. Michel

    Version of Record online : 29 AUG 2008, DOI: 10.1111/j.1471-4159.2008.05651.x

  20. You have full text access to this OnlineOpen article
    Role of the MPTP in conditioning the heart – translatability and mechanism

    British Journal of Pharmacology

    Volume 172, Issue 8, April 2015, Pages: 2074–2084, S-B Ong, R K Dongworth, H A Cabrera-Fuentes and D J Hausenloy

    Version of Record online : 8 JAN 2015, DOI: 10.1111/bph.13013